{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:10:06Z","timestamp":1752228606955,"version":"3.41.2"},"reference-count":27,"publisher":"Jaypee Brothers Medical Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.59556\/japi.72.0676","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:45:30Z","timestamp":1752227130000},"page":"35-37","source":"Crossref","is-referenced-by-count":0,"title":["Torsemide in the Management of Essential Hypertension"],"prefix":"10.59556","volume":"72","author":[{"given":"Kuntal","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti Lal","family":"Chandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Badani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhaval","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Advani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiron","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(12):","key":"key20250711094525_B1","doi-asserted-by":"crossref","first-page":"1874\u2013","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41","author":"Mancia","year":"2023;","journal-title":"J Hypertens"},{"key":"key20250711094525_B2","unstructured":"World Health Organization. Hypertension: fact sheet. 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension. Accessed 20 June 2024."},{"issue":"(7):","key":"key20250711094525_B3","doi-asserted-by":"crossref","first-page":"474\u2013","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"ICMR-INDIAB Collaborative Study Group. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).","volume":"11","author":"Anjana","year":"2023;","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20250711094525_B4","unstructured":"Tackling G, Borhade MB. Hypertensive heart disease. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539800\/s. Accessed 20 June 2024."},{"issue":"(2):","key":"key20250711094525_B5","first-page":"e35449.","article-title":"Hypertension control cascade and regional performance in india: a repeated cross-sectional analysis (2015-2021).","volume":"15","author":"Basu","year":"2023;","journal-title":"Cureus"},{"key":"key20250711094525_B6","unstructured":"Huxel C, Raja A, Ollivierre-Lawrence MD. Loop diuretics. [Updated 2023 May 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546656\/. Accessed [date accessed]."},{"key":"key20250711094525_B7","unstructured":"Drugs Controller General of India. Approval of fixed dose combinations. 2019. Available from: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadApprovalMarketingFDC\/approvfdcfeb19.pdf. Accessed 20 June 2024."},{"issue":"(6):","key":"key20250711094525_B8","doi-asserted-by":"crossref","first-page":"387\u2013","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy.","volume":"339","author":"Brater","year":"1998;","journal-title":"N Engl J Med"},{"issue":"(4):","key":"key20250711094525_B9","doi-asserted-by":"crossref","first-page":"396\u2013","DOI":"10.1177\/106002809502900411","article-title":"Torsemide: a pyridine-sulfonylurea loop diuretic.","volume":"29","author":"Blose","year":"1995;","journal-title":"Ann Pharmacother"},{"issue":"(9):","key":"key20250711094525_B10","first-page":"1\u2013","article-title":"Pathophysiology of hypertension and its cause.","volume":"11","author":"Cheng","year":"2022;","journal-title":"J Mol Pathophysiol"},{"key":"key20250711094525_B11","volume-title":"Understanding Pathophysiology,","author":"Craft","year":"2011.","edition":"3rd edition."},{"issue":"(2):","key":"key20250711094525_B12","doi-asserted-by":"crossref","first-page":"154\u2013","DOI":"10.1097\/01.pap.0000249938.05382.d0","article-title":"Update of diuretics in the treatment of hypertension.","volume":"14","author":"Padilla","year":"2007;","journal-title":"Am J Ther"},{"issue":"(4):","key":"key20250711094525_B13","doi-asserted-by":"crossref","first-page":"27.","DOI":"10.1007\/s11906-016-0636-7","article-title":"Loop diuretics in the treatment of hypertension.","volume":"18","author":"Malha","year":"2016;","journal-title":"Curr Hypertens Rep"},{"issue":"(Suppl 3):","key":"key20250711094525_B14","first-page":"S1\u2013","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group.","year":"2021;","journal-title":"Kidney Int"},{"issue":"(Suppl 3):","key":"key20250711094525_B15","doi-asserted-by":"crossref","first-page":"S32\u2013","DOI":"10.1097\/00005344-199322003-00005","article-title":"Torasemide in the treatment of arterial hypertension.","volume":"22","author":"Luft","year":"1993;","journal-title":"J Cardiovasc Pharmacol"},{"issue":"(5):","key":"key20250711094525_B16","first-page":"CD003825.","article-title":"Blood pressure-lowering efficacy of loop diuretics for primary hypertension.","volume":"2015","author":"Musini","year":"2015;","journal-title":"Cochrane Database Syst Rev"},{"issue":"(21)","key":"key20250711094525_B17","doi-asserted-by":"crossref","first-page":"3766\u2013","DOI":"10.2174\/13816128113199990315","article-title":"Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.","volume":"19","author":"Tziomalos","year":"2013;","journal-title":"Curr Pharm Des"},{"issue":"(2):","key":"key20250711094525_B18","doi-asserted-by":"crossref","first-page":"104\u2013","DOI":"10.2165\/00002018-199614020-00005","article-title":"Benefits and risks of torasemide in congestive heart failure and essential hypertension.","volume":"14","author":"Brater","year":"1996;","journal-title":"Drug Saf"},{"issue":"(4):","key":"key20250711094525_B19","doi-asserted-by":"crossref","first-page":"27\u2013","DOI":"10.26442\/SG29205","article-title":"Features of the use of torasemide in arterial hypertension.","volume":"14","author":"Baryshnikova","year":"2017;","journal-title":"Syst Hypertens"},{"issue":"(1):","key":"key20250711094525_B20","doi-asserted-by":"crossref","first-page":"138\u2013","DOI":"10.1161\/01.HYP.34.1.138","article-title":"Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.","volume":"34","author":"Fortu\u00f1o","year":"1999;","journal-title":"Hypertension"},{"issue":"(27):","key":"key20250711094525_B21","doi-asserted-by":"crossref","first-page":"2507\u2013","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for hypertension in advanced chronic kidney disease.","volume":"385","author":"Agarwal","year":"2021;","journal-title":"N Engl J Med"},{"issue":"(4):","key":"key20250711094525_B22","first-page":"265\u2013","article-title":"Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study.","volume":"2","author":"Dupont","year":"1988;","journal-title":"J Hum Hypertens"},{"issue":"(1):","key":"key20250711094525_B23","first-page":"11.","article-title":"The relationship of lifestyle with hypertension incidence in Antang public health center of Makassar city.","volume":"1","author":"Susanti","year":"2020;","journal-title":"Health Sci"},{"issue":"(6):","key":"key20250711094525_B24","doi-asserted-by":"crossref","first-page":"950\u2013","DOI":"10.1080\/07420520802544589","article-title":"Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension.","volume":"25","author":"Hermida","year":"2008;","journal-title":"Chronobiol Int"},{"issue":"(1A):","key":"key20250711094525_B25","first-page":"190\u2013","article-title":"Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.","volume":"38","author":"Spannbrucker","year":"1988;","journal-title":"Arzneimittelforschung"},{"issue":"(2):","key":"key20250711094525_B26","doi-asserted-by":"crossref","first-page":"91\u2013","DOI":"10.1111\/j.1527-3466.2008.00046.x","article-title":"Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release.","volume":"26","author":"Roca-Cusachs","year":"2008;","journal-title":"Cardiovasc Ther"},{"issue":"(1):","key":"key20250711094525_B27","first-page":"151\u2013","article-title":"Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.","volume":"260","author":"Stroobandt","year":"1982;","journal-title":"Arch Int Pharmacodyn Ther"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:45:39Z","timestamp":1752227139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-9-s1-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.59556\/japi.72.0676"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0676","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}